Eye disease study aims to speed up future treatments
NCT ID NCT04127006
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This study follows 103 adults with a genetic eye condition called retinitis pigmentosa caused by EYS mutations. Researchers will track changes in vision and eye structure over 4 years. The goal is to better understand how the disease progresses so that future clinical trials can be designed more effectively.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EYE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier National d'Ophtalmologie des Quinze-Vingts
Paris, 75012, France
-
Colorado Retina Associates
Denver, Colorado, 80230, United States
-
Duke University Eye Center
Durham, North Carolina, 27710, United States
-
Emory Eye Center
Atlanta, Georgia, 30322, United States
-
Hadassah Medical Center
Jerusalem, Israel, Israel
-
Helsinki University Hospital
Helsinki, Finland
-
Hospital for Sick Children
Toronto, Canada
-
Kellogg Eye Center, University of Michigan
Ann Arbor, Michigan, 48105, United States
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
-
Oregon Health Science University Casey Eye Institute
Portland, Oregon, 97239, United States
-
Radboud University
Nijmegen, Netherlands
-
Retina Foundation of the Southwest
Dallas, Texas, 75231, United States
-
University of California, San Francisco
San Francisco, California, 94143-0344, United States
-
University of Miami: Neuro-ophthalmology Department
Miami, Florida, 33136, United States
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
-
University of Tubingen
Tübingen, Germany
-
University of Wisconsin-Madison: McPherson Eye Research Institute
Madison, Wisconsin, 53705, United States
-
Vitreo-Retinal Associates
Gainesville, Florida, 32607, United States
-
Wilmer Eye Institute at Johns Hopkins
Baltimore, Maryland, 21287-9277, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single eye injection restore sight in genetic blindness?
- A sharper look at the retina: new imaging technology may spot eye disease earlier
- Stem cell eye transplant aims to halt blindness from rare genetic disease
- Could stem cells restore sight in damaged eyes?
- Gene therapy injection aims to restore sight in rare blindness
- 5,000 seniors join landmark eye health study to unlock secrets of aging vision